These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2112554)

  • 21. Dynamics of pituitary down-regulation and ovarian response to controlled stimulation in in vitro fertilization cycles.
    Mohamed KA; Davies WA; Lashen H
    Fertil Steril; 2007 Feb; 87(2):433-5. PubMed ID: 17094983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Escape from the down-regulation of the pituitary-ovarian axis following decreased infusion of luteinizing hormone-releasing hormone agonist.
    Lemay A; Sandow J; Quesnel G; Bergeron J; Mérat P
    Fertil Steril; 1988 May; 49(5):802-8. PubMed ID: 3129314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum IGF-1 concentrations following pituitary desensitization do not predict the ovarian response to gonadotrophin stimulation prior to IVF.
    Keay SD; Liversedge NH; Akande VA; Mathur RS; Jenkins JM
    Hum Reprod; 2003 Sep; 18(9):1797-801. PubMed ID: 12923130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The optimum dose and mode of administration of luteinizing hormone releasing hormone analogue in in-vitro fertilization: a comparison of three regimens.
    Wren M; Tan SL; Waterstone J; Parsons J
    Hum Reprod; 1991 Nov; 6(10):1370-2. PubMed ID: 1770128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary down-regulation prior to in-vitro fertilization and embryo transfer: a comparison between a single dose of Zoladex depot and multiple daily doses of Suprefact.
    Oyesanya OA; Teo SK; Quah E; Abdurazak N; Lee FY; Cheng WC
    Hum Reprod; 1995 May; 10(5):1042-4. PubMed ID: 7657737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum placental protein 14 concentrations are similar in the first trimester pregnancies of women after pituitary down-regulation with a gonadotrophin-releasing hormone agonist and normal cycles with frozen embryo transfers.
    Miettinen T; Tiitinen A; Koistinen R; Julkunen M; Seppälä M
    Hum Reprod; 1994 Dec; 9(12):2429-31. PubMed ID: 7714170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P; Domingo M; Leader A
    Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of low-dose triptorelin on pituitary down-regulation for patients undergoing in vitro fertilization and embryo transfer].
    Zhu WJ; Li XM; Chen XM; Zhang L
    Zhonghua Nan Ke Xue; 2003 Aug; 9(5):367-9. PubMed ID: 14513648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of ovarian response after suppression with a gonadotropin releasing hormone agonist in different chronological periods prior to gonadotropin stimulation for in vitro fertilization.
    Loutradis D; Kallianidis K; Sakellaropoulos G; Dokos J; Siskos K; Creatsas G; Deligeoroglou E; Michalas S; Aravantinos D
    Gynecol Obstet Invest; 1991; 32(2):68-71. PubMed ID: 1748325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG.
    Smitz J; Devroey P; Braeckmans P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
    Hum Reprod; 1987 May; 2(4):309-14. PubMed ID: 3114314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of pharmacological hypogonadotropism using gonadotropin-releasing hormone agonists in patients undergoing controlled ovarian stimulation.
    Lindner C; Braendle W; Lichtenberg V; Bettendorf G
    Gynecol Obstet Invest; 1990; 29(2):132-9. PubMed ID: 2139863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of hormonal changes during combined buserelin/HMG treatment.
    Urbancsek J; Rabe T; Grunwald K; Kiesel L; Runnebaum B
    Hum Reprod; 1990 Aug; 5(6):675-81. PubMed ID: 2123882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the intensity of downregulation on outcome of in vitro fertilization and embryo transfer.
    Lam PM; Cheung LP; Choy CM; Lau YP; Haines C
    Gynecol Endocrinol; 2002 Apr; 16(2):143-50. PubMed ID: 12012625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative trial between an ultra-short and long protocol of luteinizing hormone-releasing hormone agonist for ovarian stimulation in in-vitro fertilization.
    Marcus SF; Brinsden PR; Macnamee M; Rainsbury PA; Elder KT; Edwards RG
    Hum Reprod; 1993 Feb; 8(2):238-43. PubMed ID: 8473427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of buserelin and nafarelin in IVF cycles and in subsequent frozen-thawed embryo transfer cycles.
    Simberg N; Tulppala M; Husa LM; Tiitinen A
    Acta Obstet Gynecol Scand; 1998 Sep; 77(8):854-9. PubMed ID: 9776601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utero-ovarian blood flow characteristics of pituitary desensitization.
    Dada T; Salha O; Allgar V; Sharma V
    Hum Reprod; 2001 Aug; 16(8):1663-70. PubMed ID: 11473960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis.
    Nakamura K; Oosawa M; Kondou I; Inagaki S; Shibata H; Narita O; Suganuma N; Tomoda Y
    J Assist Reprod Genet; 1992 Apr; 9(2):113-7. PubMed ID: 1627925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and endocrinological changes in women following ovulation induction using buserelin acetate/human menopausal gonadotrophin augmented with biosynthetic human growth hormone.
    Hughes SM; Huang ZH; Matson PL; Buck P; Lieberman BA; Morris ID
    Hum Reprod; 1992 Jul; 7(6):770-5. PubMed ID: 1500473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C; Donnez J; Loumaye E
    Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute pituitary-ovarian response during chronic luteinizing hormone-releasing hormone agonist administration in polycystic ovarian syndrome.
    Faure N; Lemay A
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):403-10. PubMed ID: 3150825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.